Ghana Medical Trust Fund Gains Momentum with GH¢200,000 Fidelity Bank Donation and Novartis Strategic Partnership

The Ghana Medical Trust Fund (GMTF) has received a significant boost in its mission to provide specialized healthcare, securing both a substantial financial donation from Fidelity Bank Ghana and a strategic endorsement from global healthcare giant Novartis. These developments underscore a growing public-private synergy aimed at addressing the increasing burden of chronic non-communicable diseases (NCDs) and expanding access to high-cost medical treatments across the country. The GMTF serves as a critical bridge for patients whose medical needs exceed the coverage provided by the National Health Insurance Scheme (NHIS).

On September 15, 2026, Fidelity Bank Ghana contributed GH¢200,000 to the Fund, specifically targeting support for vulnerable patients requiring specialized care for chronic conditions. Leading a delegation to the Fund’s office, the bank’s Deputy Managing Director, Mr. Kwabena Boateng, emphasized that the donation is a core part of the institution’s corporate social responsibility. He noted that improving healthcare access is a critical pillar for national development, reaffirming the bank's commitment to ensuring that financial barriers do not prevent citizens from receiving life-saving treatments.

This financial support complements the international backing provided by Novartis, which has described the GMTF as a "critical and timely" initiative. Dr. Lutz Hegeman, President of Global Health and Swiss Country Director for Novartis, expressed the company's readiness to collaborate with the Trust Fund on several fronts, including medical research, the provision of advanced medical equipment, and the specialized training of Ghanaian healthcare professionals. This partnership is expected to significantly enhance clinical outcomes for patients suffering from long-term chronic conditions by introducing global expertise into the local healthcare landscape.

Mrs. Adjoa Obuobia Darko-Opoku, the Administrator of the GMTF, has highlighted the vital role the Fund plays in managing high-cost treatments. She pointed to recent milestones, such as the commissioning of a Cardiac Catheterisation Laboratory and the construction of new cardiology centers, as evidence of the Fund’s tangible impact. Expressing gratitude to the donors, she noted that such collaborations are essential to meeting the growing healthcare demands and ensuring that specialized care—ranging from cardiac procedures to chronic disease management—remains accessible to all Ghanaians.

As the GMTF continues to expand its reach, the collaboration between the state and private sector leaders serves as a model for sustainable healthcare financing in Ghana. By combining financial contributions with technical expertise and research capacity, the Trust Fund aims to create a more resilient healthcare system. Moving forward, the Fund plans to leverage these partnerships to further modernize medical facilities and ensure that economic status does not dictate a patient's ability to survive chronic illness.